43769 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 19
00:32 UTC
|
CRDO
Credo Technology Group
|
◎ Target | Sean O'Loughlin ★★☆☆☆ #2536 | Buy | $260.00→ $300.00+15.4% |
|
Aug 19
00:32 UTC
|
CPB
Campbell's
|
◎ Target | Thomas Palmer ★★★☆☆ #1674 | Neutral | $20.00→ $22.00+10.0% |
|
Aug 19
00:32 UTC
|
CLMT
Calumet
|
◎ Target | Neil Mehta ★★★☆☆ #1252 | Neutral | $40.00→ $45.00+12.5% |
|
Aug 19
00:32 UTC
|
CIEN
Ciena
|
◎ Target | Joshua Buchalter ★☆☆☆☆ #2976 | Buy | $675.00→ $575.00-14.8% |
|
Aug 19
00:32 UTC
|
CHYM
Chime Financial
|
◎ Target | James Faucette ★★★☆☆ #1134 | Overweight | $33.00→ $39.00+18.2% |
|
Aug 19
00:32 UTC
|
CHH
Choice Hotels International
|
◎ Target | Stephen Grambling ★★★☆☆ #1506 | Underweight | $86.00→ $91.00+5.8% |
|
Aug 19
00:32 UTC
|
CBLL
CeriBell
|
◎ Target | Marie Thibault ★★★★☆ #713 | Buy | $28.00→ $30.00+7.1% |
|
Aug 19
00:32 UTC
|
BP
BP
|
◎ Target | firm only | Buy | GBX 600→ GBX 605+0.8% |
|
Aug 19
00:32 UTC
|
BMRN
BioMarin Pharmaceutical
|
◎ Target | Mitchell S. Kapoor not yet tracked | Neutral | $60.00→ $59.00-1.7% |
|
Aug 19
00:32 UTC
|
BBWI
Bath & Body Works
|
◎ Target | Matthew Boss ★★★★☆ #902 | Neutral | $22.00→ $24.00+9.1% |
|
Aug 19
00:32 UTC
|
ARGX
argenex
|
◎ Target | Luca Issi ★★★☆☆ #1921 | Outperform | $1,025.00→ $1,100.00+7.3% |
|
Aug 19
00:32 UTC
|
ARGX
argenex
|
◎ Target | David Nierengarten ★★☆☆☆ #2446 | Outperform | $1,050.00→ $1,150.00+9.5% |
|
Aug 19
00:32 UTC
|
ARGX
argenex
|
◎ Target | Jason N. Butler not yet tracked | Market Outperform | $932.00→ $1,200.00+28.8% |
|
Aug 19
00:32 UTC
|
ARGX
argenex
|
◎ Target | Douglas Tsao ★★★☆☆ #1644 | Buy | $940.00→ $1,202.00+27.9% |
|
Aug 19
00:32 UTC
|
ARGX
argenex
|
◎ Target | Sean Laaman ★★★☆☆ #1060 | Overweight | $1,200.00→ $1,230.00+2.5% |
|
Aug 19
00:32 UTC
|
ARGX
argenex
|
◎ Target | Danielle Brill ★★★☆☆ #2034 | Buy | $1,030.00→ $1,095.00+6.3% |
|
Aug 19
00:32 UTC
|
APR.UN
Automotive Properties Real Est Invt TR
|
◎ Target | firm only | Outperform | C$13.00→ C$13.50+3.8% |
|
Aug 19
00:32 UTC
|
AORT
Artivion
|
◎ Target | William Plovanic ★★★★☆ #570 | Buy | $39.00→ $40.00+2.6% |
|
Aug 19
00:32 UTC
|
ANF
Abercrombie & Fitch
|
◎ Target | Matthew Boss ★★★★☆ #902 | Neutral | $110.00→ $126.00+14.5% |
|
Aug 19
00:32 UTC
|
AMPH
Amphastar Pharmaceuticals
|
◎ Target | Glen Santangelo ★★★★☆ #690 | Equal Weight | $20.00→ $23.00+15.0% |
|
Aug 19
00:32 UTC
|
AMLX
Amylyx Pharmaceuticals
|
◎ Target | Andrew S. Fein not yet tracked | Buy | $34.00→ $55.00+61.8% |
|
Aug 19
00:32 UTC
|
AMGN
Amgen
|
◎ Target | Carter Gould ★★★★★ #249 | Neutral | $350.00→ $400.00+14.3% |
|
Aug 19
00:32 UTC
|
AMGN
Amgen
|
◎ Target | Salim Syed ★★★☆☆ #1719 | Neutral | $303.00→ $352.00+16.2% |
|
Aug 19
00:32 UTC
|
AEO
American Eagle Outfitters
|
◎ Target | Matthew Boss ★★★★☆ #902 | Neutral | $19.00→ $21.00+10.5% |
|
Aug 19
00:32 UTC
|
ADNT
Adient
|
◎ Target | Andrew Percoco ★★☆☆☆ #2683 | Equal Weight | $22.00→ $21.00-4.5% |
|
Aug 19
00:32 UTC
|
ACQ
AutoCanada
|
◎ Target | firm only | Sec→ r Perform | C$23.00→ C$24.00+4.3% |
|
Aug 18
19:31 UTC
|
SMA
Smartstop Self Storage REIT
|
◎ Target | firm only | Outperform | $38.50→ $39.25+1.9% |
|
Aug 18
19:31 UTC
|
LUCA
Luca Mining
|
◎ Target | firm only | Outperform | C$2.50→ C$2.40-4.0% |
|
Aug 18
19:31 UTC
|
APR.UN
Automotive Properties Real Est Invt TR
|
◎ Target | firm only | Outperform | C$13.00→ C$13.50+3.8% |
|
Aug 18
19:31 UTC
|
ACQ
AutoCanada
|
◎ Target | firm only | Sec→ r Perform | C$23.00→ C$24.00+4.3% |
|
Aug 18
18:31 UTC
|
PGY
Pagaya Technologies
|
◎ Target | John Hecht ★★★☆☆ #1747 | Buy | $23.00→ $27.00+17.4% |
|
Aug 18
18:31 UTC
|
INTS
Intensity Therapeutics
|
◎ Target | Swayampakula Ramakanth ★★☆☆☆ #2738 | Buy | $5.00→ $7.00+40.0% |
|
Aug 18
18:31 UTC
|
AMPH
Amphastar Pharmaceuticals
|
◎ Target | Glen Santangelo ★★★★☆ #690 | Equal Weight | $20.00→ $23.00+15.0% |
|
Aug 18
18:31 UTC
|
AMLX
Amylyx Pharmaceuticals
|
◎ Target | Andrew S. Fein not yet tracked | Buy | $34.00→ $55.00+61.8% |
|
Aug 18
17:31 UTC
|
PSA
Public Storage
|
◎ Target | Nicholas Yulico ★★★★☆ #820 | Outperform | $345.00→ $346.00+0.3% |
|
Aug 18
17:31 UTC
|
OLLI
Ollie's Bargain Outlet
|
◎ Target | Peter Keith ★★★★☆ #579 | Overweight | $114.00→ $113.00-0.9% |
|
Aug 18
17:31 UTC
|
NTAP
NetApp
|
◎ Target | Asiya Merchant ★★★☆☆ #1657 | Neutral | $150.00→ $209.00+39.3% |
|
Aug 18
17:31 UTC
|
EYPT
Eyepoint Pharmaceuticals
|
◎ Target | Yigal Nochomovitz ★★☆☆☆ #2787 | Buy | $17.00 |
|
Aug 18
17:31 UTC
|
CRM
Salesforce
|
◎ Target | Tyler Radke ★★★★★ #316 | Neutral | $187.00→ $204.00+9.1% |
|
Aug 18
17:31 UTC
|
ARGX
argenex
|
◎ Target | Danielle Brill ★★★☆☆ #2034 | Buy | $1,030.00→ $1,095.00+6.3% |
|
Aug 18
16:31 UTC
|
WES
Western Midstream Partners
|
◎ Target | Robert Kad ★★★☆☆ #1323 | Equal Weight | $51.00→ $55.00+7.8% |
|
Aug 18
16:31 UTC
|
TRGP
Targa Resources
|
◎ Target | Robert Kad ★★★☆☆ #1323 | Overweight | $333.00→ $343.00+3.0% |
|
Aug 18
16:31 UTC
|
TRGP
Targa Resources
|
◎ Target | Julien Dumoulin-Smith not yet tracked | Buy | $324.00→ $345.00+6.5% |
|
Aug 18
16:31 UTC
|
PAGP
Plains GP
|
◎ Target | Robert Kad ★★★☆☆ #1323 | Equal Weight | $26.00→ $28.00+7.7% |
|
Aug 18
16:31 UTC
|
OKTA
Okta
|
◎ Target | Joseph Gallo ★★★★★ #120 | Buy | $140.00→ $170.00+21.4% |
|
Aug 18
16:31 UTC
|
LUNR
Intuitive Machines
|
◎ Target | Austin Moeller ★☆☆☆☆ #3175 | Buy | $41.00→ $39.00-4.9% |
|
Aug 18
16:31 UTC
|
EYPT
Eyepoint Pharmaceuticals
|
◎ Target | Yigal Nochomovitz ★★☆☆☆ #2787 | Buy | $35.00→ $17.00-51.4% |
|
Aug 18
16:31 UTC
|
DT
Dynatrace
|
◎ Target | Fatima Boolani ★★★★★ #257 | Buy | $62.00→ $65.00+4.8% |
|
Aug 18
15:31 UTC
|
WMB
Williams Companies
|
◎ Target | Robert Kad ★★★☆☆ #1323 | Overweight | $99.00→ $103.00+4.0% |
|
Aug 18
15:31 UTC
|
VSXY
Victoria's Secret & Co.
|
◎ Target | Mauricio Serna ★★★★☆ #351 | Neutral | $90.00→ $95.00+5.6% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.